Daniel Fehling, LL.M. (University of Auckland)

Lawyer, Partner*

Practice Areas

  • (Cross-border) Transactions (M&A, PE), both buy and sell side, share and asset deals
  • Advising in all matters of corporate law, i.a. restructurings
  • Providing advise to (family) businesses, family offices, financial investors, strategic investors and entrepreneurs
  • Focuses on consumer goods, shipping, logistics, technology and service provider
Show moreShow less
Education and Professional Experience
  • Partner at GSK Stockmann since 2024
  • Admitted to practise law in Germany (2010)
  • Certified specialist for commercial and corporate law
  • Certified specialist for banking and capital markets law
  • Previously worked at an international commercial law firm (2013 to 2023, from 2020 to 2023 as partner) and two medium-sized firms specialising in commercial and corporate law and litigation (2010 to 2013)
  • Legal traineeship at the Celle Higher Regional Court from 2008 to 2010
  • Master of Laws (LL.M.) in Commercial Law from the University of Auckland, New Zealand (2007)
  • Law studies with additional qualification in Anglo-American law from the University of Trier and the University of Athens (2001 to 2006)
Languages
  • German, English
Memberships
  • Anglo-German Club e.V. in Hamburg
Awards
  • Recommended lawyer in the field of “Corporate Law” (The Legal 500 2024)
GSK Updates
27 February 2025

Family-owned businesses and private equity – Maintaining the company culture and family values as a (contractual) condition

Subject to careful negotiations, it is possible to have both, to exploit growth potential that would otherwise be difficult to realise

Read more
Deal News
20 December 2024

GSK Stockmann advises B+N on Köberl Group takeover

GSK Stockmann provided comprehensive advice to the Hungarian firm B+N Referencia Zrt. based in Budapest on its takeover of the Köberl Group based in Aschheim near Munich. The...

Read more
Law firm
02 January 2024

Daniel Fehling joins GSK Stockmann’s corporate/M&A team

Daniel Fehling (42) will be joining GSK Stockmann’s Hamburg team as an equity partner on 1 January 2024.

Read more

Past Events